Table of Contents Table of Contents
Previous Page  5 / 152 Next Page
Information
Show Menu
Previous Page 5 / 152 Next Page
Page Background Journal of Clinical Virology 82S (2016) S1–S142

Contents lists available at

ScienceDirect

Journal of Clinical Virology

journal homepage:

www.elsevier.com/locate/jcv

Abstracts of the 19th Annual Meeting of the European Society for

Clinical Virology, 14th–17th September 2016, Lisbon

Abstract no: 75

Presentation at ESCV 2016: Oral 1

Medico-economic impact of the rapid diagnosis

of influenza in paediatric emergency

department by using a new sensitive

chromatographic immunoassay

A. Cantais

1 ,

, O. Mory

1

, M. Costille

1

, A. Carlino

2

,

A. Cantais

1 , A. G

iraud

1 , B. P

ozzetto

2 , S. P

illet

2

1

Paediatric Emergency Department, University

Hospital of Saint-Étienne, France

2

Laboratory of Infectious Agents and Hygiene,

University Hospital of Saint-Étienne, Saint-Étienne,

France

Background:

The practicability of rapid immunochromato-

graphic antigen detection tests (RIADT) for the diagnosis of

influenza allows their use by non-trained healthcare profession-

als, even beside the bed of the patient. Newly designed assays such

as the Becton Dickinson (BD) Veritor

TM

System for Rapid Detection

of Flu A + B have shown improved analytical performances. How-

ever, the medico-economic impact of their direct implementation

in clinical wards has been poorly evaluated.

Objectives:

(1) To measure the impact of the rapid diagnosis

of influenza by using the Veritor

TM

System directly in the pae-

diatric emergency room, on the care of patients and notably on

the reduction of supplementary investigations and antibiotics dur-

ing the 2015–2016 winter season, and (2) to verify the analytical

performances of this new test.

Study design:

A nasopharyngeal aspirate was performed to

all the patients aged between 0 and 18 years consulting at the

paediatric emergency department of the University Hospital of

Saint-Etienne during the 2016 influenza season. The presence of

influenza A and B viruses was tested with the Veritor

TM

System

in the emergency room 24/7. The clinical specimen was also sent

to the laboratory in order to perform routine tests in the opening

hours, including the detection of viral antigens by immunofluores-

cence (bioMérieux) or of viral RNA by using a laboratory-developed

RT-qPCR assay on the BDMAX platform. In case of discrepant result

between the different assays, the final diagnosis was assessed by

the RT-qPCR assay. Before performing the Veritor

TM

System, the

clinician was asked to fill in a questionnaire listing the tests that

he/she would have prescribed in the absence of the rapid test-

ing; the same questionnaire was completed after the result of the

Veritor

TM

test was available.

Results:

A total of 514 patients (sex ratio M/F: 1.11; median of

age 2.7 years) were included between January 7 andMarch 19 2016.

Comparative results between the RIADT and the routine assays

were available for 477 specimens, including 45 and 185 positive

ones for influenza A and influenza B, respectively. For influenza

virus A, the sensitivity, specificity, negative predictive value and

positive predictive value were 94.9, 98.2, 96.4 and 97.4%, respec-

tively; for influenza virus B, they were 97.4, 96.4, 98.2 and 94.9%

respectively. The use of the RIADT at the emergency room saved

the prescription of: 51.7% of C-reactive protein (CRP) dosage in cap-

illary blood, 47.9% of blood sampling, 49.2% of CRP measurement,

57.4% of procalcitonin dosage, 68.8% of blood culture, 41.6% of urine

test strip, 79.2% of cytobacteriological examination of urine, 69.0%

of chest X-rays, 77.8% of lumbar puncture, 43.8% of hospitalization

and 70.1% of antibiotics.

Conclusions:

The excellent analytical performances of the

Veritor

TM

System allow its use as point-of-care test to perform an

accurate and rapid diagnosis of influenza at the paediatric emer-

gency room. In addition to deliver a rapid etiological diagnosis,

this strategy was found to save the prescription of a considerable

amount of unnecessary tests and antibiotics.

http://dx.doi.org/10.1016/j.jcv.2016.08.002

Abstract no: 306

Presentation at ESCV 2016: Oral 2

Molecular characterization of human

rhinovirus in Portugal: 2014–2015 season

P. Cristóvão

, P. Pechirra, P. Conde, I. Costa,

R. Guiomar

National Influenza and Other Respiratory Viruses

Reference Laboratory, Infectious Diseases

Department, National Institute of Health Dr. Ricardo

Jorge, Lisbon, Portugal

Background:

Human rhinoviruses (HRV) frequently cause mild

upper respiratory tract infections and more severe disease mani-

festations such as bronchiolitis and pneumonia. Plays an important

role in asthma and chronic lung disease exacerbations. Genetic

characterization of HRVs detected by molecular methods has

revealedmuch greater diversity, enabling the identification of three

species (HRV-A, HRV-B and HRV-C) and a great number of types.

The aim of this study is to characterize HRV detected in respira-

tory specimens from influenza-like illness cases (ILI), received in

1386-6532/